Hence then, the article about vanda pharmaceuticals announces orphan drug designation granted for vca 894a a novel antisense oligonucleotide candidate for the treatment of charcot marie tooth disease type 2s was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Vanda Pharmaceuticals Announces Orphan Drug Designation Granted for VCA-894A, a Novel Antisense Oligonucleotide Candidate for the Treatment of Charcot-Marie-Tooth Disease, Type 2S )
Also on site :
- Ukraine will try “to get some concessions” from Trump at meeting
- Getting hired in 2026 is all about your ‘microcredentials’ says CEO of $1.3 billion learning platform—this is what he tells Gen Z to focus on
- Teens arrested after large disturbance, multiple fights at Joliet mall